Sorin announced that it received regulatory clearance and is launching in the U.S. its SMARTVIEW Remote Monitoring System that keeps watch of the company’s Sorin PARADYM RF implanted cardiac devices.
The system includes an at-home unit that communicates wirelessly with the implant and transmits stored data about patient readings and device function to the patient and appropriate clinicians. Using these readings, a cardiologist can monitor disease progression and determine whether the implant needs to be reprogrammed.
From the announcement:
PARADYM™ RF devices are the only clinically proven ICDs that both reduce RV pacing below one percent, and offer the lowest recorded inappropriate shock rate of any devices available to date. The addition of remote monitoring to the PARADYM™ RF family of devices provides a powerful combination of advanced diagnostic capabilities, early detection of cardiac disease progression, and patient convenience.
Installation of the SMARTVIEW remote monitoring system at the patient’s home is assisted by a dedicated helpdesk provided by Sorin. This unique technical set-up assistance provides patients with peace of mind and removes the installation workload from healthcare professionals. Once the system is installed, patients use the SMARTVIEW system to transmit data electronically from their implanted cardiac device to their physicians.
Using the patient data transmitted from home, healthcare providers will have access to the most current information from their patients’ device, which may help detect potential health issues before they become life-threatening and provide timely therapy. For some patients, this may mean fewer office visits and less time traveling to and from their clinics, and will help increase efficiencies in clinicians’ management of a growing number of device patients.
Product page: SMARTVIEW Remote Monitoring System…